Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

International Journal of Rheumatology
Volume 2013, Article ID 954292, 9 pages
http://dx.doi.org/10.1155/2013/954292
Research Article

The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression

1Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, 145 Shan Dong Zhong Road, Shanghai 200001, China
2Department of Rheumatology, First Affiliated Hospital of Medical School, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China
3Department of Nephrology, Renji Hospital, Shanghai Jiaotong University School of Medicine, 145 Shan Dong Zhong Road, Shanghai 200001, China

Received 24 March 2013; Revised 9 May 2013; Accepted 28 May 2013

Academic Editor: Kenneth C. Kalunian

Copyright © 2013 Chuan-Yin Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Mok, “Prognostic factors in lupus nephritis,” Lupus, vol. 14, no. 1, pp. 39–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Cameron, “Lupus nephritis,” Journal of the American Society of Nephrology, vol. 10, no. 2, pp. 413–424, 1999. View at Google Scholar · View at Scopus
  3. P. Bhat and J. Radhakrishnan, “B lymphocytes and lupus nephritis: new insights into pathogenesis and targeted therapies,” Kidney International, vol. 73, no. 3, pp. 261–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. D. Cohen, N. Calvaresi, S. Armelloni et al., “CD20-positive infiltrates in human membranous glomerulonephritis,” Journal of Nephrology, vol. 18, no. 3, pp. 328–333, 2005. View at Google Scholar · View at Scopus
  5. H. L. Martins, C. Silva, D. Martini, and I. L. Noronha, “Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens,” Transplantation Proceedings, vol. 39, no. 2, pp. 432–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. O. M. Steinmetz, U. Panzer, U. Kneissler et al., “BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection,” Kidney International, vol. 67, no. 4, pp. 1616–1621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Angeli, F. Ginhoux, J. Llodrà et al., “B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization,” Immunity, vol. 24, no. 2, pp. 203–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Segerer and D. Schlöndorff, “B cells and tertiary lymphoid organs in renal inflammation,” Kidney International, vol. 73, no. 5, pp. 533–537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. O. M. Steinmetz, J. Velden, U. Kneissler et al., “Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis,” Kidney International, vol. 74, no. 4, pp. 448–457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Moore, O. Belvedere, A. Orr et al., “BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator,” Science, vol. 285, no. 5425, pp. 260–263, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. P. Cancro, D. P. D'Cruz, and M. A. Khamashta, “The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 119, no. 5, pp. 1066–1073, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. T. Chu, P. Enghard, S. Schürer et al., “Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 60, no. 7, pp. 2083–2093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Neusser, M. T. Lindenmeyer, I. Edenhofer et al., “Intrarenal production of B-cell survival factors in human lupus nephritis,” Modern Pathology, vol. 24, no. 1, pp. 98–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and rheumatism, vol. 40, no. 9, article 1725, 1997. View at Google Scholar · View at Scopus
  15. J. J. Weening, V. D. D'Agati, M. M. Schwartz et al., “The classification of glomerulonephritis in systemic lupus erythematosus revisited,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 241–250, 2004. View at Google Scholar
  16. H. A. Austin III, L. R. Muenz, and K. M. Joyce, “Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome,” Kidney International, vol. 25, no. 4, pp. 689–695, 1984. View at Google Scholar · View at Scopus
  17. A. D. Salama and C. D. Pusey, “Drug insight: Rituximab in renal disease and transplantation,” Nature Clinical Practice Nephrology, vol. 2, no. 4, pp. 221–230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Aloisi and R. Pujol-Borrell, “Lymphoid neogenesis in chronic inflammatory diseases,” Nature Reviews Immunology, vol. 6, no. 3, pp. 205–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Chang, S. G. Henderson, D. Brandt et al., “In situ B Cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis,” Journal of Immunology, vol. 186, no. 3, pp. 1849–1860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. G. Ng, A. P. R. Sutherland, R. Newton et al., “B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells,” Journal of Immunology, vol. 173, no. 2, pp. 807–817, 2004. View at Google Scholar · View at Scopus
  21. G. S. Cheema, V. Roschke, D. M. Hilbert, and W. Stohl, “Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases,” Arthritis & Rheumatism, vol. 44, no. 6, pp. 1313–1319, 2001. View at Google Scholar
  22. T. M. Seyler, Y. W. Park, S. Takemura et al., “BLyS and APRIL in rheumatoid arthritis,” Journal of Clinical Investigation, vol. 115, no. 11, pp. 3083–3092, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Groom, S. L. Kalled, A. H. Cutler et al., “Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 59–68, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. L. D. Zhao, Y. Li, M. F. Smith Jr. et al., “Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients,” Lupus, vol. 19, no. 13, pp. 1534–1549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Wallace, W. Stohl, R. A. Furie et al., “A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus,” Arthritis Care and Research, vol. 61, no. 9, pp. 1168–1178, 2009. View at Publisher · View at Google Scholar · View at Scopus